Active Choice in the EHR to Promote Statin Therapy
Completed · Not applicable
Conditions studied: Cardiovascular Diseases
In brief
Cardiovascular (CV) events are the leading cause of mortality in the United States. Statins have been demonstrated to be an effective tool for reducing CV events and mortality, but statins are often either not prescribed or under-prescribed for patients that meet evidence-based guidelines. In this study, we will evaluate a health system initiative using active and passive choice prompts in the electronic health record to prompt cardiologists to prescribe evidence-based statin therapy. In partnership with the health system, this will be conducted as a randomized, controlled trial to evaluate its effect.
Key facts
- Study ID
- NCT03271931
- Run by
- University of Pennsylvania
- People needed
- 23066
- Starts
- 2018-09-24
- Expected to finish
- 2019-06-05
- Last updated by the study team
- 2019-07-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have a cardiologist at the University of Pennsylvania Health System
- Meets 2013 ACC/AHA or NLA guidelines for statin prescription
You may not qualify if…
- Allergy to statins
- Severe renal insufficiency defined as glomerular filtration rate (GFR) less than 30 mL/min or on dialysis
- Adverse reaction to statins including a) myopathy, b)rhabdomyolysis, c)hepatitis
- Pregnant
- On a PCSK9 Inhibitor medication
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.